Anbio Biotechnology Class A Ordinary Shares
General ticker "NNNN" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $1.0B (TTM average)
Anbio Biotechnology Class A Ordinary Shares follows the US Stock Market performance with the rate: 34.6%.
Estimated limits based on current volatility of 14.9%: low 30.56$, high 41.26$
Factors to consider:
- Total employees count: 27 as of 2024
Short-term NNNN quotes
Long-term NNNN plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $23.54MM | $6.71MM | $8.19MM |
| Operating Expenses | $13.35MM | $4.75MM | $6.19MM |
| Operating Income | $10.20MM | $1.96MM | $2.00MM |
| Non-Operating Income | $-0.18MM | $0.29MM | $0.38MM |
| Interest Expense | $0.01MM | $0.00MM | $0.00MM |
| R&D Expense | $0.20MM | $0.13MM | $0.45MM |
| Income(Loss) | $10.01MM | $2.25MM | $2.37MM |
| Profit(Loss)* | $10.01MM | $2.25MM | $2.37MM |
| Stockholders Equity | $12.55MM | $14.82MM | $17.19MM |
| Inventory | $0.35MM | $0.00MM | $0.00MM |
| Assets | $13.96MM | $15.81MM | $18.92MM |
| Operating Cash Flow | $4.45MM | $0.90MM | $2.08MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-1.53MM | $1.73MM | $0.34MM |
| Financing Cash Flow | $0.00MM | $-0.04MM | $-0.34MM |
| Earnings Per Share** | $0.07 | $0.02 | $0.06 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.